Company Filing History:
Years Active: 2011
Title: The Innovative Mind of Jun-Sheng Li
Introduction: Jun-Sheng Li, a notable inventor based in Shanhua, Taiwan, has made significant contributions to the field of biotechnology through his research and inventions. With a focus on anti-inflammatory activities and probiotic properties, Li's work demonstrates the powerful intersection of health and innovation.
Latest Patents: Jun-Sheng Li holds one patent, which discloses two isolates—designated GMNL-76 and GMNL-89. These isolates possess anti-inflammatory activities and beneficial probiotic properties. They have been deposited in the Biosource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) and the China Center for Type Culture Collection (CCTCC), with respective accession numbers BCRC 910355 and BCRC 910340, as well as CCTCC M 207153 and CCTCC M 207154. This patented invention has potential applications in various food products and pharmaceutical compositions aimed at treating inflammation-associated diseases such as rheumatoid arthritis.
Career Highlights: Jun-Sheng Li plays a pivotal role at Genmont Biotech Incorporation, where he applies his expertise in biotechnology to develop innovative solutions. His work not only showcases his commitment to advancing health sciences but also emphasizes the importance of research in driving technological progress.
Collaborations: Collaborating with talented coworkers such as Tu-Wen Yu and Feng-Ching Hsieh, Jun-Sheng Li has fostered an environment of creativity and collaboration. Together, they contribute to ongoing advancements in biotechnological research and development.
Conclusion: Jun-Sheng Li's inventive journey is a testament to the impact of dedicated researchers in the field of biotechnology. His patent on GMNL-76 and GMNL-89 highlights the potential of natural isolates in creating solutions for health issues, showcasing the essential role that innovation plays in improving human well-being. As he continues his work at Genmont Biotech Incorporation, the future is bright for further advancements stemming from his expertise and collaborative efforts.